CMS stock forecast, quote, news & analysis

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CMS's RSI Indicator exited the oversold zone, 10 of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 53%.

The Moving Average Convergence Divergence (MACD) for CMS just turned positive on October 02, 2026. Looking at past instances where CMS's MACD turned positive, the stock continued to rise in 26 of 53 cases over the following month. The odds of a continued upward trend are 49%.

Following a +0.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where CMS advanced for three days, in 167 of 349 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.

CMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.

The Aroon Indicator for CMS entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.055) is normal, around the industry mean (2.169). P/E Ratio (18.828) is within average values for comparable stocks, (35.749). Projected Growth (PEG Ratio) (2.257) is also within normal values, averaging (1.785). Dividend Yield (0.036) settles around the average of (0.037) among similar stocks. P/S Ratio (2.291) is also within normal values, averaging (187.392).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. CMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 61 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 55, placing this stock slightly worse than average.

The Tickeron SMR rating for this company is 66 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.